Skip to content

Clinical trials

Phase 1 Encephalitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Encephalitis Phase: Phase 1 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20171
20181
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
California Pacific Medical Center Research Institute1
National Institute of Allergy and Infectious Diseases (NIAID)1
Pfizer1
SRI International1
Sarepta Therapeutics, Inc.1
Stony Brook University1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Encephalitis7
HIV Infections2
Toxoplasmosis2
Toxoplasmosis, Cerebral2
Acquired Immunodeficiency Syndrome1
Alphavirus Infections1
Autism Spectrum Disorder1
Brain Diseases1
Central Nervous System Diseases1
Central Nervous System Infections1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.